Friday 30 April 2021
Cannabis Stock Interview Alert; CEO of Global Cannabis Applications Corp. (CSE: $APP.C) (OTC: $FUAPF)
Delta, Kelowna, BC - April 30, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's special edition of cannabis news and stocks to watch plus insight from thought leaders and experts, featuring an exclusive interview with Brad Moore, CEO of Global Cannabis Applications Corp. (CSE: APP) (OTC: FUAPF).
Global Cannabis Applications Corp, ("GCAC") is a global leader in designing, developing, SaaS licensing and acquiring innovative blockchain data technologies for the medical cannabis industry.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/042621-Cannabis-GCAC.mp3
Investor Ideas Potcasts, Cannabis News and Stocks on the Move: Interview with CEO of Global Cannabis Applications Corp. (CSE: APP) (OTC: FUAPF)
SHARE PODCAST: 
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Brad Moore, CEO of Global Cannabis Applications Corp. (CSE: APP) (OTC: FUAPF) discusses the recent launch of the GCAC token on Uniswap as part of a digital marketing campaign aimed at the one million decentralized finance user community 'DeFi,' as well their definitive three-year software licensing agreement with Herb Industries Ltd., a Malta-based medical cannabis cultivator.
Commenting on the GCAC Uniswap token Moore said, "A large portion of our consumer base, and when I say our consumer base I'm talking about the CBD, recreational marijuana and medical cannabis consumer base, are people between ages 30 to 45, millennials starting families and also the people willing to use cannabis products, and cannabis as a whole, without a lot of the preconceptions and stereotypes. They are more open to ideas and understanding, and because they're more open, they have also embraced cryptocurrencies. We understand that this is a target demographic. The reason we did the GCAC token marketing program part of the opportunity, is because our whole business is based on the Ethereum Blockchain. Actually we were the first cannabis company globally to announce our Ethereum 2.0 rollup-centric roadmap. So, it only makes sense that we start marketing to like-minded people."
Moore continued, "So, we entered into a two-year marketing contract with Abbey Technology in Switzerland and they designed and published the GCAC token on Ethereum, that token went out and now 400+ people who didn't know about what GCAC did with Efixii and our QR Code system now did, and that's important. At the same time, what we did was purchase a bunch of the GCAC tokens on the open market and now we've got a nice Ethereum cryptocurrency-based asset for our balance sheet. So, for all our shareholders it was a pretty good move. If it's good enough for Elon Musk to put Bitcoin on Tesla, it's good enough for Brad Moore out of Vancouver. So, for at least the next two years, we've committed to put 1% of our top line revenue into this Abbey Technology marketing program to create awareness and to keep it going. The best way to keep awareness going is to buyback GCAC tokens with this 1% after each and every financial quarter."
As reported last month on Global News, "Tesla (NASDAQ:TSLA) customers could now buy its electric vehicles with bitcoin marking a significant step forward for the cryptocurrency's use in commerce."
"You can now buy a Tesla with bitcoin," Musk said on Twitter, adding that the option would be available outside the United States later this year.
For GCAC, their multi-year marketing campaign aims to raise awareness of its Citizen Green products and it's Efixii 'QR codes' by launching a Uniswap token on the Ethereum blockchain with the Company's name, logo and website visible to all of the Uniswap community.
GCAC's Uniswap-inclusion marketing initiative is to commit to a marketing-spend of 1% of its quarterly sales revenue buying GCAC tokens on Uniswap every 3 months. Each Uniswap token-buy should lead to greater awareness of the Company's products and drive potential new cannabis consumers to look for Efixii 'QR codes' on the products they are purchasing on-line.
Moore went on to discuss how their recent deal with Herb Industries ties in with their recent marketing campaign. "When you take a look at Herb Industries, by far our biggest deal, they're projected to do 44 million grams in 2022, and you look at my goal for 98 million grams by next year, that's pretty much 50% of that target in that one deal alone. With the revenues that we bring in, up to a potential $160,000 buying GCAC tokens on the Uniswap market, so it's very timely that the deal closed, and we planned to do the token marketing around 4/20, because it shows we are committed to marketing to this demographic. We want consumers to know that, with Efixii, there's a better and safer way to consume cannabis products."
GCAC is licensing its Citizen Green Efixii platform as part of Herb's 'technology farm' for use in its cannabis compliance and consumer transparency platform. Herb's advanced-growth-method handles all production lifecycles from genetics, cannabis nursery, onsite ISO laboratory and extraction. Licensed by the Maltese government, Herb's 12,000 SQM facility's manufacturing lines will export to other EU members' markets for pharmaceuticals, solids, semi solids, liquids, flowers, cosmetics and edibles.
GCAC's Software-as-a-Service license model meets the needs of cultivators as they scale. Cannabis lifecycle steps are represented by GCAC's Efixii QR-code which can be scanned by customs officials, regulators, medical professionals and consumers alike to ensure that products are what they claim to be. GCAC charges a one-time configuration fee of $12,500 (USD), $50 per registered employee per month for KYC/AML, an export fee of $75 per cannabis batch and a consumer Efficacy-QR-code fee of $75 per retail product; in total, these fees generate CDN$.20/gram with a further potential yield of CDN$.18/gram in future data sales.
"44M grams in 2022 and 66M grams every year thereafter is an absolutely massive revenue opportunity for us on a per gram basis" states GCAC's CEO, Brad Moore. "And just as important, is knowing that tens of thousands of EU consumers trust Efixii's QR-codes to give them, and their families comfort knowing what they are ingesting is the safest and best product for them, thereby cementing our efficacy commitment of better outcomes for medical cannabis patients and recreational consumers."
The European cannabis market is the largest in the world, with a forecast CAGR of 67.4% set to value the market at €3.2 billion by 2025. The growth of the EU market since 2019 is attributed to consumer demand for CBD and the upgrading of regulations for medical cannabis. Key to meeting those regulations and building consumer confidence will be Herb's use of the Efixii compliance platform. Efixii enables growers' staff to record all events for cannabis cultivations, including mother plant, laboratory tests, shipment, processing and customs.
Moore went on to discuss in more detail his personal story dealing with cancer and the difficulty navigating the current medical cannabis landscape, the long term potential of the Efixii QR Code system for the medical cannabis industry as well as how blockchain could influence the future of cannabis regulations.
"I really want people to understand this. In the same way that cryptocurrency has upended banking, blockchain, in our industry, can help create the framework for meaningful regulations and better cannabis products."
About Global Cannabis Applications Corp. "GCAC"
GCAC is a global leader in designing, developing, SaaS licensing and acquiring innovative data technologies for the medical cannabis industry. The Citizen Green and Efixii platforms are the world's first end-to-end - from patient to regulator - medical cannabis data solutions. They use six core technologies: mobile applications, artificial intelligence, RegTech, smart databases, Ethereum blockchain and GCAC smart rewards. These technologies transparently disclose cannabis chain-of-custody events, thereby enabling patients to provide crowd-sourced medical cannabis efficacy data. Driven by digital and cannabis industry experts, GCAC is focused on generating revenue from SaaS licensing its technology and acquiring high quality cannabis datasets that improve patient outcomes and to become the world's largest cannabis efficacy data provider.
For more Company information, please visit www.cannappscorp.com, or review its profiles on www.sedar.com and on the Canadian Securities Exchange's website www.thecse.com.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The Investorideas.com podcasts are also available on iTunes (Apple Podcasts), Audible, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Play Music and most audio platforms available.
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye.
Disclaimer/Disclosure: Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. This podcast distribution featuring Global Cannabis Applications Corp.was a paid for service on Investorideas.com ( 2000) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news content services including podcasts and tag articles on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories
Buy a cannabis guest post on Investorideas.com
Thursday 29 April 2021
#CannabisExtraction #Stocks in the News (CSE: $XTRX.C) (TSX-V: $RTI.V) (TSX: $VLNS.TO) (CSE: $OILS.C) @adastra_labs @RadientInc @TheValensCo @nextleaf_oils
#CannabisExtraction #Stocks in the News (CSE: $XTRX.C) (TSX-V: $RTI.V) (TSX: $VLNS.TO) (CSE: $OILS.C) @adastra_labs @RadientInc @TheValensCo @nextleaf_oils
Point
Roberts WA, Delta, BC –April 29, 2021 - Investorideas.com, a leading
investor news resource covering cannabis and hemp stocks releases a special
report on the accelerated growth within the extracts and “Cannabis 2.0”
categories as more companies further distribution and expand R&D
capabilities, featuring Phyto
Extractions Inc. (formerly Adastra
Labs Holdings Ltd.) (CSE:XTRX).
Read this article,
featuring XTRX in full at https://www.investorideas.com/news/2021/cannabis/04291Cannabis-Extraction-Stocks.asp
The global cannabis extract market size was
valued at USD 7.3 billion in 2019 and is anticipated to register a CAGR of
16.6% over the forecast period to 2027 says Grandview Research.
One company set to capitalize on this
extract growth is Phyto Extractions Inc. (formerly Adastra Labs Holdings Ltd.)
(CSE:XTRX). Phyto
Extractions™ is an agricultural-scale cannabis extraction, distillation and
product manufacturer located in Langley, BC at its co-located Health Canada
Licensed Standard Processing (extraction and products, no cultivation), Sales
(extracts, topicals and edibles) and R&D through Adastra Labs Inc. and
Analytical Testing Laboratory through Chemia Analytics Inc.
According to Phyto Extractions
news,
“The current cannabis extract market has seen a huge boom in sales from the
past year, in which demands for cannabis extracts are rising steadily. Canadian
cannabis extract sales observed an exponential 315% growth rate for the past
two years, from 320,201 non-medical sales in Oct. 2019 to 1,328,769 sales in
Oct. 2020, and over 200% sales growth rate including all medical and
non-medical sales. Rising demand for cannabis extract products requires
reasonable supplies from producers for cannabis enthusiasts.”
The Company recently announced that it has
received its Health Canada R&D license addendum in Adastra Labs Inc. that
will permit some limited human testing by licensed researchers administering or
distributing cannabis to human research subjects using cannabis obtained from a
holder of a license for processing in the final form of cannabis.
This R&D license addendum will permit
the Company to conduct in-house human testing for taste of various cannabis
products for assessment of taste, sights, smell, or touch of cannabis.
"We look forward to initiating
human-studies and generating valuable consumer-based data to support our
product development pipeline and continue delivering high-quality efficacious
cannabis products to Canadians," stated Dr. Kyle Boniface, PhD.
The Company also announced
on April 21st they are now
producing cannabis shatter products for the Canadian market after wholly-owned
subsidiary Adastra Labs Inc.'s commissioning of new hydrocarbon extraction
equipment ahead of schedule.
From
the news: “With the arrival of the ExtractionTek
Solutions MeP XT70 system, a high-performance hydrocarbon extractor, the team
at Phyto Extractions can now process over 400 KG per day of cannabis biomass
into a variety of hydrocarbon cannabis concentrate products. Focused on shatter
production currently, this translates into over 50kg of high-quality product
output per day.”
From
the news: “Phyto Extractions™ has launched three new
shatter cannabis products: Pink Kush, Blue Gorilla OG, and D. Bubba that will
serve the over 9 million Canadians currently in the cannabis market with its
one-gram offerings. The Company's increasing market share in the disposable
vape, vape cartridge, and live resin markets, strengthens the brand's launch of
its new flagship 'shatter' product line.”
From
the news: “With relatively few players in the niche of
shatter product space in Canada, this market expansion represents a significant
opportunity given the forecasted growth of the Cannabis extract market.”
Shatter
video: https://youtu.be/Bo4VWLSAT7o
Radient
Technologies Inc. (TSX-V:
RTI)
(OTCQX:
RDDTF),
a cannabis company utilizing a
proprietary extraction and downstream processing platform, in December 2020 announced its licensing
agreement with Tunaaaaroom to manufacture and distribute a wide range of
premium cannabis extracts targeting recreational cannabis consumers in Canada.
Radient will make use of its Health Canada Cannabis Research and Analytical
Testing licenses to fully characterize the Tunaaaa strains and evaluate the
sensory qualities of extracts formulated to mimic the specific terpene profiles
and containing differing cannabinoid profiles and potencies.
Based in Edmonton, Tunaaaa has spent over
six years developing the genetics for over 1,000 high-quality cannabis strains
containing proprietary terpene profiles. Through this licensing deal, Radient
will gain access to Tunaaaa’s specific genetics and will engage the Tunaaaa
breeders as consultants to help drive product development.
Radient will further make use of its
Standard Processing and Sales Licenses to rapidly launch premium distillate dab
and vape extracts. Radient plans to bring Tunaaaa’s vast catalogue of unique
flavours to the market with monthly drops of new terp profiles. Radient and
Tunaaaa will also work in collaboration on CBD and CBN distillate dabs to
create additional unique terpene extract products for recreational cannabis consumers.
Future Radient extract products may include
Cannabis 2.0 products like diamond, shatter, caviars, live rosin, terp sauce as
well as micro cannabinoid isolates and edibles.
The
Valens Company Inc.
(TSX:
VLNS)
(OTCQX:
VLNCF),
a leading manufacturer of cannabis products, specifically in the Cannabis 2.0
product category recently
announced
expansion of its distribution in both Manitoba and the Yukon, having entered
into an agreement with the Manitoba Liquor & Lotteries Corporation to supply
and distribute a wide range of cannabis products to LGCA-licensed private
retailers in the Province of Manitoba, as well as its entry into the Yukon
market with a cannabis purchase and sale agreement with the Yukon Liquor
Corporation (YLC). With this agreement, Valens expands its distribution network
to five provinces in the country.
"Expanding our domestic distribution
capabilities is one of our top strategic initiatives to drive growth this year
and beyond," said Tyler Robson, Chief Executive Officer, Co-Founder and
Chair of The Valens Company. "Our entry into the Manitoba market takes us
a step further toward capturing larger market share and bringing the Valens
advantage to consumers in a new province, enabling greater access to our
high-quality products across Canada."
"Our entry into the Yukon market not
only furthers our ability to capture market share in Canada, but also broadens
the selection and quality of products that consumers in the territory can
access," continued Tyler Robson. "We have made significant progress
growing our cannabis distribution network and we expect to increase our
national position in the short-term as we continue discussions with other
private and government-regulated retailers across the country."
Valens has already shipped several products
to the province, including A1 Cannabis' Summit 10 THC beverages, Verse
Cannabis' Tropic Lemon and Sunset Peach vape carts and 1:20 CBD oil, with
additional product formats across various categories expected to be shipped in
the coming weeks.
Nextleaf
Solutions Ltd.
(CSE:
OILS)
(OTCQB:
OILFF),
the world's most innovative cannabis processor, announced in March, 2021
that it has commenced human trials of cannabis vapes.
Under its amended Cannabis Research Licence
from Health Canada, Nextleaf is collecting sensory evaluation data from
qualified volunteers completing organoleptic assessments of a wide variety of
formulated cannabis vape products. The Company is comprehensively testing a
range of cannabinoid and terpene formulations, including how various vape
hardware interacts with different formulations. Nextleaf expects to accelerate
product development and drastically shorten design cycles for launching new
cannabis vape products by validating formulations and delivery technologies
more efficiently.
Forbes wrote a feature around Nextleaf's
human trial program on March 30, 2021 and the article can
be read here.
"The amended Cannabis Research Licence
allows Nextleaf to rapidly formulate a wide variety of cannabis products and
administer samples to volunteer research participants," said Nextleaf
Solutions R&D Lead, Dr. David Novitski. "The ability to provide
commercial partners with data-based consumer insights around taste and overall
user experience is a true game changer for product development."
Since becoming legal in Canada, vapes have
emerged as the clear leader of all cannabis 2.0 products. According to the most
recent data from the Ontario Cannabis Store, the vape category ranks second
only to dried flower with 15.7% of all Ontario cannabis sales. In more mature
adult-use markets like Colorado, Oregon, and Washington, the market share for
cannabis vapes reached as high as 22.3%, according to data from Headset. As
Canada continues to roll out brick and mortar cannabis retail stores, the vape
segment is expected to continue to increase in overall size and market share.
The Company believes the CBD vape subcategory could see significant growth
should Health Canada regulations change to allow for increased legal access to
CBD products. Nextleaf plans to validate its proprietary CBD vape technology
under its amended Cannabis Research Licence.
Collecting data-based consumer insights is
particularly important in an increasingly competitive market in which initial
product launches can dictate the long-term success of a brand.
"There are a lot of subpar vape
products available in the market today that have not gone through rigorous
testing and human trials," said Nextleaf Solutions CEO Paul Pedersen.
"Issues such as poor taste, clogging, leaking, and crystallization in CBD
vapes are well documented throughout the industry. Collecting consumer feedback
during product development is key to launching differentiated cannabis 2.0
products that provide consumers with a positive experience and value."
Considering the recent cannabis investments
by large pharmaceutical and tobacco companies, it is apparent that generating
and protecting intellectual property is becoming more important in the next
phase of the industry's maturation. Management believes Nextleaf is well
positioned with its product innovation pipeline and success securing issued
patents in the United States. Nextleaf owns 12 US patents and has been issued
over 70 patents globally. Innovation is core to Nextleaf's value proposition,
and its ability to differentiate with its patented and patent pending
cannabinoid delivery technologies and formulations. The amended Cannabis
Research Licence allows Nextleaf to continue to develop, validate, and
strengthen its R&D within a federally legal market.
As we see more extract companies expanding
their R&D and distribution capabilities, we see a three-fold gain to the
industry. This will create accelerated growth and competition in the category,
higher quality products for consumers which will be more effective through
proper research, as well as important industry data points through having
access to proper research techniques which can have a massive benefit to both
the medical and recreational market moving forward.
As both the Canadian and US cannabis
industries begin to enter into a state of maturation and stability we see the
Cannabis 2.0 product category continue to gain a larger sales footing which can
only be expected to grow further as consumer awareness rises along with product
consistency and availability.
About
Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Our
site does not make recommendations for purchases or sale of stocks, services or
products. Nothing on our sites should be construed as an offer or solicitation
to buy or sell products or securities. All investing involves risk and possible
losses. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. Contact management and IR of
each company directly regarding specific questions. Disclosure: this
news article featuring XTRX is a paid for news release on
Investorideas.com (two thousand) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp
Learn more about publishing your news release and our other news services on
the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Contact
Investorideas.com
800-665-0411
Get more Cannabis Stock
Investor Ideas - news, articles, podcasts and
stock directories
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move: Interview with CEO of Global Cannabis Applications Corp. (CSE: $APP.C) (OTC: $FUAPF) @CitizenGreenWld
Investor Ideas #Potcasts,
#Cannabis News and #Stocks on the Move: Interview with CEO of Global Cannabis
Applications Corp. (CSE: $APP.C) (OTC: $FUAPF) @CitizenGreenWld
Delta, Kelowna, BC, April 29, 2021 (Investorideas.com Newswire) www.Investorideas.com,
a global news source covering leading sectors including marijuana and hemp
stocks and its potcast site, www.potcasts.ca release
today’s special edition of cannabis news
and stocks to watch plus insight from thought leaders and experts, featuring an
exclusive interview with Brad Moore, CEO of Global Cannabis Applications Corp. (CSE:
APP)
(OTC:
FUAPF).
Global Cannabis Applications Corp, (“GCAC”)
is a global leader in designing, developing, SaaS licensing and acquiring
innovative blockchain data technologies for the medical cannabis industry.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/042621-Cannabis-GCAC.mp3
Read this in full
at https://www.investorideas.com/news/2021/cannabis-potcasts/04291APP-FUAPF.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Brad
Moore, CEO of Global Cannabis
Applications Corp. (CSE:
APP)
(OTC:
FUAPF) discusses the
recent launch
of the GCAC token on Uniswap as part of a
digital marketing campaign aimed at the one million decentralized finance user
community ‘DeFi,’ as well their
definitive three-year software licensing agreement with Herb Industries Ltd., a Malta-based
medical cannabis cultivator.
Commenting
on the GCAC Uniswap token Moore said, “A large portion of our consumer base,
and when I say our consumer base I’m talking about the CBD, recreational
marijuana and medical cannabis consumer base, are people between ages 30 to 45,
millennials starting families and also the people willing to use cannabis products,
and cannabis as a whole, without a lot of the preconceptions and stereotypes.
They are more open to ideas and understanding, and because they’re more open,
they have also embraced cryptocurrencies. We understand that this is a target
demographic. The reason we did the GCAC token marketing program part of the
opportunity, is because our whole business is based on the Ethereum Blockchain. Actually we were the
first cannabis company globally to announce our Ethereum 2.0 rollup-centric roadmap. So, it
only makes sense that we start marketing to like-minded people.”
Moore
continued, “So, we entered into a two-year marketing contract with Abbey Technology
in Switzerland and they designed and published the GCAC token on Ethereum, that
token went out and now 400+ people who didn’t know about what GCAC did with
Efixii and our QR Code system now did, and that’s important. At the same time,
what we did was purchase a bunch of the GCAC tokens on the open market and now
we’ve got a nice Ethereum cryptocurrency-based asset for our balance sheet. So,
for all our shareholders it was a pretty good move. If it’s good enough for
Elon Musk to put Bitcoin on Tesla, it’s good enough for Brad Moore out of
Vancouver. So, for at least the next two years, we’ve committed to put 1% of
our top line revenue into this Abbey Technology marketing program to create
awareness and to keep it going. The best way to keep awareness going is to buyback
GCAC tokens with this 1% after each and every financial quarter.”
As reported last month on Global
News, “Tesla (NASDAQ:TSLA) customers
could now buy its electric vehicles with bitcoin marking a significant step
forward for the cryptocurrency’s use in commerce.”
“You can now buy a Tesla with
bitcoin,” Musk said on Twitter, adding that the option would be available
outside the United States later this year.
For GCAC, their multi-year marketing
campaign aims to raise awareness of its Citizen Green products and it’s Efixii
‘QR codes’ by launching a Uniswap token on the Ethereum blockchain with the
Company’s name, logo and website visible to all of the Uniswap community.
GCAC’s Uniswap-inclusion marketing
initiative is to commit to a marketing-spend of 1% of its quarterly sales
revenue buying GCAC tokens on Uniswap every 3 months. Each Uniswap token-buy
should lead to greater awareness of the Company’s products and drive potential
new cannabis consumers to look for Efixii ‘QR codes’ on the products they are
purchasing on-line.
Moore went on to discuss how their
recent deal with Herb Industries ties in with their recent marketing campaign.
“When you take a look at Herb Industries, by far our biggest deal, they’re projected
to do 44 million grams in 2022, and you look at my goal for 98 million grams by
next year, that’s pretty much 50% of that target in that one deal alone. With
the revenues that we bring in, up to a potential $160,000 buying GCAC tokens on
the Uniswap market, so it’s very timely that the deal closed, and we planned to
do the token marketing around 4/20, because it shows we are committed to
marketing to this demographic. We want consumers to know that, with Efixii,
there’s a better and safer way to consume cannabis products.”
GCAC is licensing its Citizen Green
Efixii platform as part of Herb’s ‘technology farm’ for use in its cannabis
compliance and consumer transparency platform. Herb’s advanced-growth-method
handles all production lifecycles from genetics, cannabis nursery, onsite ISO
laboratory and extraction. Licensed by the Maltese government, Herb’s 12,000
SQM facility’s manufacturing lines will export to other EU members’ markets for
pharmaceuticals, solids, semi solids, liquids, flowers, cosmetics and edibles.
GCAC’s Software-as-a-Service license
model meets the needs of cultivators as they scale. Cannabis lifecycle steps
are represented by GCAC’s Efixii QR-code which can be scanned by customs
officials, regulators, medical professionals and consumers alike to ensure that
products are what they claim to be. GCAC charges a one-time configuration fee
of $12,500 (USD), $50 per registered employee per month for KYC/AML, an export
fee of $75 per cannabis batch and a consumer Efficacy-QR-code fee of $75 per
retail product; in total, these fees generate CDN$.20/gram with a further
potential yield of CDN$.18/gram in future data sales.
“44M grams in 2022 and 66M grams
every year thereafter is an absolutely massive revenue opportunity for us on a
per gram basis” states GCAC’s CEO, Brad Moore. “And just as important, is
knowing that tens of thousands of EU consumers trust Efixii’s QR-codes to give
them, and their families comfort knowing what they are ingesting is the safest
and best product for them, thereby cementing our efficacy commitment of better
outcomes for medical cannabis patients and recreational consumers.”
The European cannabis market is the
largest in the world, with a forecast CAGR of 67.4% set to value the market at
€3.2 billion by 2025. The growth of the EU market since 2019 is attributed to
consumer demand for CBD and the upgrading of regulations for medical cannabis.
Key to meeting those regulations and building consumer confidence will be
Herb’s use of the Efixii compliance platform. Efixii enables growers’ staff to
record all events for cannabis cultivations, including mother plant, laboratory
tests, shipment, processing and customs.
Moore
went on to discuss in more detail his personal story dealing with cancer and
the difficulty navigating the current medical cannabis landscape, the long term
potential of the Efixii QR Code system for the medical cannabis industry as
well as how blockchain could influence the future of cannabis regulations.
“I
really want people to understand this. In the same way that cryptocurrency has
upended banking, blockchain, in our industry, can help create the framework for
meaningful regulations and better cannabis products.”
About Global
Cannabis Applications Corp. “GCAC”
GCAC
is a global leader in designing, developing, SaaS licensing and acquiring
innovative data technologies for the medical cannabis industry. The Citizen
Green and Efixii platforms are the world's first end-to-end - from patient to
regulator - medical cannabis data solutions. They use six core technologies:
mobile applications, artificial intelligence, RegTech, smart databases,
Ethereum blockchain and GCAC smart rewards. These technologies transparently
disclose cannabis chain-of-custody events, thereby enabling patients to provide
crowd-sourced medical cannabis efficacy data. Driven by digital and cannabis
industry experts, GCAC is focused on generating revenue from SaaS licensing its
technology and acquiring high quality cannabis datasets that improve patient
outcomes and to become the world’s largest cannabis efficacy data provider.
For
more Company information, please visit www.cannappscorp.com, or review its
profiles on www.sedar.com and on the Canadian Securities Exchange's website www.thecse.com.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The
Investorideas.com podcasts are also available on iTunes ( Apple Podcasts)
, Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio , Google Play
Music and most audio platforms available.
About
Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure:
Our site does not make recommendations for purchases or sale of stocks,
services or products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investing involves risk
and possible losses. This site is currently compensated for news publication
and distribution, social media and marketing, content creation and more.
Disclosure is posted for each compensated news release, content published
/created if required but otherwise the news was not compensated for and was
published for the sole interest of our readers and followers. This podcast distribution featuring Global Cannabis Applications Corp.was
a paid for service on Investorideas.com ( 2000) More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news content services including podcasts
and tag articles on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to
regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Subscribe to:
Posts (Atom)
Stocks to Watch Battling the Opioid Epidemic; Stocks Mentioned in this article: Greenlane Holdings, Inc. (NASDAQ: $GNLN), Safe Supply Streaming Co Ltd. (CSE: $SPLY.CN), Nutriband Inc. (NASDAQ: $NTRB), QuidelOrtho Corporation (Nasdaq: $QDEL), Emergent BioSolutions Inc. (NYSE: $EBS)
Stocks to Watch Battling the Opioid Epidemic ; Stocks Mentioned in this article: Greenlane Holdings, Inc. (NASDAQ: $GNLN), Safe Supply St...
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ... -
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: $DIXI_U.C) (OTC: $DXBRF), Khiron Life Sciences (T... -
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...